Raphael Pharmaceutical accepted for OTCQB up-list, to trade under 'RAPH'

Raphael Pharmaceutical Inc.

Application submitted September 1, 2022; notified of acceptance on October 7, 2022.
Will trade on OTCQB under ticker symbol 'RAPH' after trading approval from OTC Markets.
Company has paid required fees and increased financial transparency to meet OTCQB standards.
Management believes the up-list better positions the company for a greater growth trajectory.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.